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A 
t the conclusion of the 1986 Immunology Congress in 
Toronto,  the  late  Georges  K6hler  presented  a  sum- 
mary lecture which was, unfortunately, poorly attended.  It 
dealt with the impact of the new genetics on immunology, 
and, among other wise things, he said that transgenic tech- 
nology was set to revolutionize the way we studied immu- 
nologic  tolerance  (1).  The  greatest barrier to  uncovering 
the details of what happened to anti-self cells in the repertoire 
was the heterogeneity oflymphocytes. Cells potentially re- 
active with a given self antigen were so rare that most at- 
tempts to study their fate retied on inferential rather than 
direct  methods.  Successful  attempts  to  create  mice  trans- 
genic for both heavy (H) and tight (L) immunoglobutin (Ig) 
chains, or for the oe and [3 chains of the recently discovered 
T  cell receptor (TCR) in theory, at least, had the potential to 
create monoclonal mice, i.e., animals in which all or at least 
the greater part of the B or T  cell population consisted only 
of cells bearing the transgenically imposed specificity. Anti- 
idiotypic reagents could identify such cells,  or, even more 
easily, simple enumeration  of B  or T  cell numbers under 
various experimental circumstances could yield information 
about the fate of anti-self cells. 
How tight K6hler was; but it took some time to prove 
it. Burnet first articulated the concept of clonal deletion as 
the key mechanism of tolerance, postulating that if an en- 
counter between  a self antigen  and a  cell reactive with it 
occurred in early life, while the immune system was imma- 
ture,  clonal deletion rather than clonal selection would be 
the  end  result  (2).  Lederberg refined  this  notion,  placing 
the transition from paralyzability to inducibility at the level 
of each differentiating immunocyte, regardless of the age of 
the animal (3). When it first became possible to enumerate 
antigen-binding B cells by autoradiographic techniques, early 
results  indeed  favored deletion  as  a  tolerance  mechanism 
(4).  For T  cells,  it was still  necessary to rely on functional 
techniques to support repertoire purging as a tolerance mecha- 
nism as not  even enumeration  of antigen-specific precur- 
sors of effector T  cells by in vitro cloning techniques could 
distinguish clonal deletion from some form of effective non- 
lethal silencing (5). However, the latter concept had articu- 
late supporters on theoretical grounds (6). Careful work on 
antigen-specific B  cells,  involving both their enumeration 
and purification,  showed that high doses of antigen  could 
cause clonal deletion, but tolerance could be achieved with 
much lower doses, this non-deletional phenomenon being 
termed clonal anergy (7). Support for clonal anergy among 
T  lymphocytes also gradually emerged (8, 9). 
Enter transgenic mouse technology. As far as B  cell tol- 
erance was concerned,  the first results were disappointing. 
Antigen-transgenic mice were either non-tolerant or vari- 
ably tolerant (10,  11). However, antigen-transgenic animals 
were not the main game, as they left the investigator with 
the task of studying the minority of (unidentifiable) reactive 
lymphocytes. Things really took off when B  (12,  13)  or T 
(14)  cell  receptor  transgenic  mice  were  used.  From  the 
viewpoint of the present story (15),  the critical model was 
an ingeniously devised double-transgenic  strategy (12;  re- 
viewed in 16, 17). Mice were rendered transgenic for mono- 
clonal B  cell IgM and IgD receptors with high affinity for 
hen egg lysozyme (HEL) and such mice were mated with 
mice transgenic for HEL itself. Further features of the model 
were a capacity to distinguish transgenic from endogenous 
antibody via an allotype marker; the use of various founder 
lines  constitutively producing  various  amounts  of soluble 
HEL (s-HEL); a capacity to raise low HEL levels to high 
ones through zinc feeding in mice where the metallothio- 
nein  promoter  formed  part  of the  HEL  transgenic  con- 
struct;  and  comparison  of the  effects  of s-HEL  with  a 
membrane-anchored form of the  same antigen  (m-HEL). 
Some key findings of this model were as follows, s-HEL at 
very low concentrations  caused T  cell tolerance but with 
no  discernible  effects on the B  cell compartment.  Higher 
concentrations also resulted in T  cell tolerance but in addi- 
tion  caused a non-deletional,  clonal anergy type of B  cell 
tolerance,  readily observed as the great majority of B  cells 
carried the transgenic Ig. This B  cell tolerance was accom- 
panied by a down-modulation of surface IgM and a marked 
shortening of the B  cell's life-span (18).  The transgenic B 
cells clustered chiefly in follicular areas of the spleen, espe- 
cially  the  mantle  zone  of the  follicles.  Only  when  the 
strongly  cross-linking signal  of transgenic  m-HEL was  in 
place did a deletional type of tolerance, representing clonal 
elimination shortly after Ig expression (while the immature 
B cell was still in the bone marrow) become manifest. Still, 
the delayed deletion of the anergic cells at 3-4 d does raise 
the question of whether anergy in B cells is entirely discrete 
from "clonal abortion" (19). 
The  plot  thickens  as  we  move to  studies  that  seek  to 
track the migration of transgenic B  cells  after transfer into 
various kinds  of host  mice  (20).  Anti-HEL B  cells  trans- 
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coming to  occupy much the  same location  as within  the 
donor animal. A similar trafficking pattern was noted when 
the transgenic B cells were transferred to doubly s-HEL-anti- 
HEL transgenic mice. However, when the anti-HEL (anti- 
neo-self) B cells find themselves in a minority among a di- 
verse B cell repertoire, and still in the presence of the HEL 
antigen, something different happens. Transferred B cells still 
appear in the white pulp of the spleen, and soon move to 
the  outer part of the  T  cell trafficking area,  the  so-called 
peri-arteriolar lymphocyte sheath or PALS, where they come 
to  occupy an area just  outside  the  follicle,  at the follicle/ 
PALS border.  They do not penetrate into the follicle, but 
appear to die within a day or two. 
To understand  the interpretation  that  Cyster et al.  (20) 
place on these findings, we must first present some further 
curious facts. Newly formed B cells leave the bone marrow 
in very large numbers every day and home predominantly 
to the spleen (21).  At this stage of their lives, they are pre- 
dominantly IgM  high IgD  l~  B cells, and these cells are rather 
short-lived, having largely disappeared by a week or so.  If 
B  cells  from lymph nodes,  from thoracic  duct lymph,  or 
from other parts of the recirculating lymphocyte pool are 
examined,  these  possess  a  different  phenotype.  They  are 
Ig-M  l~  lgD  high, recirculating, follicular mantle-seeking and 
they live for several weeks. These cells are not memory B 
cells,  in that they display no or very few Ig V  gene muta- 
tions, are not isotype switched, and do not carry memory if 
adoptively transferred from immunized mice. Yet they are 
different from virgin, just emerging B cells, in that they ex- 
hibit  a  different and more restricted  Ig V  gene repertoire 
(22).  It is as though  this population has either been posi- 
tively selected by contact with  antigen,  but  not in  a way 
sufficient to induce isotype switch or Ig V  gene hypermu- 
ration; and/or lacks cells  (perhaps a very large population) 
that have been negatively selected through reactivity against 
self antigens. Against this background, Cyster et al. (20) pos- 
tulate that the follicular micro-environment is necessary for 
B  cells  to  undergo  some final maturational  steps.  Only if 
they reach the  follicles can B  cells  undergo  these pheno- 
typic  changes.  They  explain  their  findings  by suggesting 
that there is competition between B  cells for access  to the 
follicles.  Anergic B cells manage to get to the follicles pro- 
vided  they  are  the  only kind  of B  cell around,  as in  the 
doubly transgenic  s-HEL-anti-HEL mice.  Set  up  a  situa- 
tion  (there are actually three different models in their pa- 
per)  where  the  anergic  cells,  still  "handicapped"  by  the 
presence of antigen,  are in the minority among a normal, 
diverse B  cell repertoire and the anergic cells  fail to reach 
the follicles and soon die. This exclusion of cells with anti-self 
potential from follicles is seen as a potent weapon against 
autoinmlunity as the cell does not have longevity conferred 
upon it and also does not reach the recirculating pool. 
In the article that is the subject of the present Commen- 
tary, Fulcher and Basten (15)  also examine the fate of self- 
reactive B  cells after transfer in the same transgenic model, 
adding  several  elegant  tricks  to  the  experimental  design. 
They track transferred cells  by prelabeling them with  the 
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stable intracellular dye 5-carboxyfluoresceine diacetate-suc- 
cinimidyl ester (CFSE).  To give a calibration device com- 
paring the fate ofanti-HEL transgenic B cells and normal B 
cells, the former were treated with a concentration of CFSE 
four-fold higher than the latter. Thus, flow cytometry can 
easily distinguish the numbers of the two transferred popu- 
lations in various organs under  different experimental cir- 
cumstances.  To study the effects of antigen concentration, 
anti-HEL  B  cells  were  transferred  into  different  founder 
lines,  with  zinc-induced  antigen  upregulation,  or  use  of 
m-HEL transgenic mice, providing further variables.  Trans- 
fer into non-transgenic mice given HEL by injection served 
as a check on s-HEL-transgenic results.  To investigate the 
influence of effective cognate T  cell help on trafficking pat- 
terns,  survival,  and  fate  of transferred  normal  or  anergic 
cells, B  and T  cell cotransfer experiments were performed. 
CFSE-labeled-anti-HEL B cells were prepulsed with a pep- 
tide  MCC87_103 from  moth  cytochrome  C.  At  the  same 
time,  CD4 + T  cells  from a TCg.-transgenic mouse,  with 
specificity for MCC87_103, preactivated in vivo one day pre- 
viously, were also transferred. Appropriate F1  hybrid mice 
with a suitable class II MHC restriction element were used. 
The  following  are  the  main  results  of the  study.  The 
shortened life-span of anti-HEL B  cells on transfer into ei- 
ther  the  standard  s-HEL transgenic  or m-HEL transgenic 
hosts was confirmed. As neither cell division (which would 
have halved  the  CFSE  labeling)  nor migration  to  lymph 
nodes  were  noted,  the  cells  probably died  in  situ  in  the 
spleen.  Some enlargement of the  anti-HEL cells  by com- 
parison with  cotransferred normal B  cells  suggested a de- 
gree of activation before death.  As noted by Cyster et al. 
(20),  the  anti-HEL B  cells  migrated to  the  PALS-follicle 
border. When anti-HEL B cells were transferred to s-HEL- 
transgenic  strains  showing  lower  HEL  serum  concentra- 
tions,  below the threshold for induction  of B  cell anergy, 
the B  cells  did reach the follicle, and persisted there for at 
least 2 d. This did not occur if the hosts had the HEL levels 
raised  by  zinc  feeding.  As  transfer  to  s-HEL-anti-HEL 
double transgenics lead to follicular localization, the ques- 
tion of the effective s-HEL concentration in the serum of 
such mice was raised. Two factors could lower these levels, 
namely  some  constitutive  anti-HEL  antibody  formation, 
and the vast pool of B cells with anti-HEL receptors acting 
as an "antigen sink." In fact, both ELISA assays and serum 
capacity to  downregulate  the  Ig receptors  of anti-HEL B 
cells demonstrated that the doubly transgenic mice had sig- 
nificantly lower levels of available HEL than singly s-HEL 
transgenic mice. These findings showed antigen concentra- 
tion to be an extremely important variable in the trafficking 
behavior and life-span of the anti-HEL B  cells. When cells 
were  transferred  to  normal  mice,  exogenously  injected 
HEL could prevent entry into follicles provided the serum 
concentration reached above threshold levels. 
The provision of T  cell help had profound effects on the 
anergic B  cells.  Obviously in  the  doubly transgenic  situa- 
tion, B cells receive no T  cell help because the T  cell pop- 
ulation is tolerant. When peptide-pulsed anergic anti-HEL 
B cells were transferred into s-HEL transgenic recipients to- 
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migrated  to  two  locations,  namely  follicles,  where  they 
generated  immature  germinal  centers,  and  the  red  pulp, 
where  proliferating foci  of antibody-secreting cells  were 
seen. By day 5, significant levels of HEL-specific IgM anti- 
body had appeared. 
The most significant difference of  interpretation between 
this paper (15) and that ofCyster et al. (20) is the reason for 
the  appearance  of anti-HEL B  cells  within follicles upon 
transfer into doubly transgenic s-HEL-anti-HEL mice. FUl- 
cher and Basten (15) claim there is no need to invoke com- 
petition for a follicular niche, as the effective concentration 
of  HEL is lower in doubly as opposed to singly (s-HEL) trans- 
genic mice, and this difference alone could alter migration 
patterns. Moreover, preincubation of anti-HEL B cells with 
HEL before transfer into doubly transgenic mice could ne- 
gate follicular entry, again suggesting that B cell behavior is 
determined by exposure to antigen above a critical thresh- 
old concentration rather than by competition between B 
cells. It is of interest that a relatively small difference in the 
degree of receptor engagement in anti-HEL B  cells,  47% 
following transfer into s-HEL transgenic mice, or 26% fol- 
lowing transfer to doubly transgenic mice, could exert such 
a major difference in behavior (23). 
It is in the outer PALS that B  cells normally receive T 
cell help and it is perhaps not surprising that it is within this 
location that they die in the absence of T  cell help if the 
partial receptor engagement, above a certain threshold, has 
given an  early and  only partial  activation signal  to  them. 
Unencumbered by antigen  they move to  their preferred 
home in the follicles. Aided by T cell help, they embark on 
the dual proliferative and differentiative pathway of germi- 
nal center formation and creation of antibody-forming cell 
foci.  The  Fulcher and Basten paper  (15)  is  silent  on  the 
question of  what maturational or other process might occur 
in follicles, in the absence of obvious antigenic stimulation, 
to confer longevity, recirculating capacity and strong IgD 
positivity on B  cells which reach the follicles.  This part of 
the Cyster et al. (20) story thus appears to be unchallenged. 
From both sets of studies, it seems that B cells with some 
degree of anti-self potential can reach the spleen and linger, 
at least  for a while,  in the PALS waiting for T  cell help. 
Such  anergic  cells  could represent a  danger for autoanti- 
body formation if some cross-reacting antigen, sharing a B 
cell epitope with the self antigen in question, but possessing 
a foreign T  cell epitope, entered the body. The relevant T 
cell help would clearly break B  cell anergy. Were that to 
occur, the chief danger would lie in germinal centers pro- 
ducing high affinity, hypermutated anti-selfB cells. For this 
reason, it is fortunate that the  germinal center appears to 
possess fail-safe mechanisms to prevent this occurring. Three 
independent and essentially simultaneous studies have shown 
that germinal center B cells are peculiarly sensitive to apop- 
tosis should they encounter antigen unattached to follicular 
dendritic  cells  (24-26).  Moreover, the  more  strongly re- 
ceptor cross-linking this stimulus,  the more extensive the 
apoptosis. This appears to be a powerful back-up to B  cell 
deletion and anergy in ensuring that the secondary, hyper- 
mutated B  cell repertoire is relatively uncontaminated by 
high affinity anti-self cells. 
Given that the somatic minigene assembly process which 
creates the B  cell repertoire is  random,  it is  obvious that 
anti-self B  cells will arise with highly variable affinities for 
the self antigen in question. Those most obviously danger- 
ous  to  the  body,  namely  exhibiting  reactivity  to  some 
prominent  self membrane-anchored protein,  such  as  self 
MHC  or self blood group antigen, will be deleted in the 
bone marrow and not allowed into the periphery. Those of 
lesser threat, e.g., directed against  a soluble self antigen, re- 
quiting  T  cell help before activation and possible affinity 
maturation  as  well,  enter  the  periphery but  may  display 
various degrees of anergy. The present work (15) prompts 
the reflection that anergy is a flexible, reversible, and quan- 
titative concept. One could imagine one extreme, shading 
into central deletion, where the anergic cell is allowed to 
leave the marrow but dies  very quickly. At the other ex- 
treme, shading into "ignorance" of the self antigen, the cell 
may suffer only a slightly shortened life-span. At either ex- 
treme, strong cognate T  cell help can rescue the cell from 
anergy, but, as originally postulated by Linton and Klinman 
(27),  the germinal center precursors to high affinity mem- 
ory cells pass through a "second window" of tolerance sus- 
ceptibility to protect the secondary repertoire. 
As the person who originated the concept of clonal an- 
ergy, following the strong lead of Bretscher and Cohn (6), 
the  present  author  compliments the  two  talented groups 
exploiting the HEL-anti-HEL transgenic model and is con- 
vinced that the moderate differences of interpretation and 
emphasis between them will soon yield to further explora- 
tions. He does wish to issue  a challenge, however. Present 
transgenic  constructs  do  not  permit  the  study of isotype 
switching in transgenic B  cells, nor has any evidence been 
presented  that  the  immature  germinal  centers  permitted 
with artificially provided T  cell help actually support Ig V 
gene hypermutation among the still IgM and IgD express- 
ing centroblasts. The effort to create transgenic B cells sus- 
ceptible to isotype switching and affinity maturation must 
surely be worthwhile. 
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